CANB Stock Analysis
CA
Uncovered
Can B Corp is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Can B Corp. engages in the development, production, and sale of products and delivery devices containing cannabidiol. The company is headquartered in Hicksville, New York. The company went IPO on 2011-03-11. The company is engaged in the manufacturing and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The firm's products include oils, creams, moisturizers, isolate gel caps, spa products, concentrates and lifestyle products. The company develops its own line of proprietary products as well seeks synergistic value through acquisitions in the hemp industry. The firm's Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. Its products are sold to consumers online, via retailers, marketing partners and events through doctors and health and wellness organizations.